In addition, cDC1s are important in the response to PD-L1 therapy [15], and patient survival has been positively correlated with the abundance of tumor-infiltrating cDC1, making cDC1 a key factor in the anti-tumor response [15,16,17]. This evidence concerns the gene MPPE1 and neoplasm.